Cargando…
Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy
Patient: Female, 30 Final Diagnosis: Minimal change disease Symptoms: Oliguria • systemic edema Medication: — Clinical Procedure: Steroid pulse therapy Specialty: Obstetrics and Gynecology OBJECTIVE: Rare disease BACKGROUND: Nephrotic syndrome occurs very rarely, in only about 0.01–0.02% of all preg...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404478/ https://www.ncbi.nlm.nih.gov/pubmed/28416778 http://dx.doi.org/10.12659/AJCR.902910 |
_version_ | 1783231606219079680 |
---|---|
author | Sato, Hiroshi Asami, Yuna Shiro, Reona Aoki, Masato Yasuda, Miki Imai, Saeko Sakai, Rie Oida, Kenji Kawaharamura, Kanako Yano, Hiroko Taguchi, Nao Suzuki, Takako Hirose, Masaya |
author_facet | Sato, Hiroshi Asami, Yuna Shiro, Reona Aoki, Masato Yasuda, Miki Imai, Saeko Sakai, Rie Oida, Kenji Kawaharamura, Kanako Yano, Hiroko Taguchi, Nao Suzuki, Takako Hirose, Masaya |
author_sort | Sato, Hiroshi |
collection | PubMed |
description | Patient: Female, 30 Final Diagnosis: Minimal change disease Symptoms: Oliguria • systemic edema Medication: — Clinical Procedure: Steroid pulse therapy Specialty: Obstetrics and Gynecology OBJECTIVE: Rare disease BACKGROUND: Nephrotic syndrome occurs very rarely, in only about 0.01–0.02% of all pregnancies, and de novo minimal change disease during pregnancy is especially rare. Nephrotic syndrome and, especially, minimal change disease are highly responsive to steroids, and preterm labor may be avoidable if the maternal condition is improved with steroid therapy. Therefore, prompt diagnosis and proper management are critical to maternal and fetal outcome when severe proteinuria occurs during pregnancy. CASE REPORT: A 30-year-old pregnant Japanese woman presented with systemic edema, oliguria, and severe proteinuria and hypoalbuminemia at 25 weeks of gestation, although she was normotensive. The patient had high urinary protein selectivity. Her illness was diagnosed as de novo nephrotic syndrome with high steroid responsiveness rather than pre-eclampsia. She began steroid pulse therapy the day after admission. Complete remission was confirmed after 3 weeks. The patient did not relapse during pregnancy and delivered a healthy male baby at 37 weeks of gestation. A renal biopsy at a relapse after delivery confirmed minimal change disease. CONCLUSIONS: In pregnant women with de novo minimal change disease, serious maternal and/or fetal complications may occur if severe proteinuria and hypoalbuminemia are unabated for an extended time. Evaluation of urinary protein selectivity is noninvasive and useful for prediction of steroid responsiveness. Results of urinary protein selectivity can be obtained earlier than results of renal biopsy. Renal biopsy during pregnancy is not always necessary for initiation of steroid therapy. Rapid initiation of steroid pulse therapy may enable quicker achievement of remission and prevent serious perinatal complications. |
format | Online Article Text |
id | pubmed-5404478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | International Scientific Literature, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54044782017-05-03 Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy Sato, Hiroshi Asami, Yuna Shiro, Reona Aoki, Masato Yasuda, Miki Imai, Saeko Sakai, Rie Oida, Kenji Kawaharamura, Kanako Yano, Hiroko Taguchi, Nao Suzuki, Takako Hirose, Masaya Am J Case Rep Articles Patient: Female, 30 Final Diagnosis: Minimal change disease Symptoms: Oliguria • systemic edema Medication: — Clinical Procedure: Steroid pulse therapy Specialty: Obstetrics and Gynecology OBJECTIVE: Rare disease BACKGROUND: Nephrotic syndrome occurs very rarely, in only about 0.01–0.02% of all pregnancies, and de novo minimal change disease during pregnancy is especially rare. Nephrotic syndrome and, especially, minimal change disease are highly responsive to steroids, and preterm labor may be avoidable if the maternal condition is improved with steroid therapy. Therefore, prompt diagnosis and proper management are critical to maternal and fetal outcome when severe proteinuria occurs during pregnancy. CASE REPORT: A 30-year-old pregnant Japanese woman presented with systemic edema, oliguria, and severe proteinuria and hypoalbuminemia at 25 weeks of gestation, although she was normotensive. The patient had high urinary protein selectivity. Her illness was diagnosed as de novo nephrotic syndrome with high steroid responsiveness rather than pre-eclampsia. She began steroid pulse therapy the day after admission. Complete remission was confirmed after 3 weeks. The patient did not relapse during pregnancy and delivered a healthy male baby at 37 weeks of gestation. A renal biopsy at a relapse after delivery confirmed minimal change disease. CONCLUSIONS: In pregnant women with de novo minimal change disease, serious maternal and/or fetal complications may occur if severe proteinuria and hypoalbuminemia are unabated for an extended time. Evaluation of urinary protein selectivity is noninvasive and useful for prediction of steroid responsiveness. Results of urinary protein selectivity can be obtained earlier than results of renal biopsy. Renal biopsy during pregnancy is not always necessary for initiation of steroid therapy. Rapid initiation of steroid pulse therapy may enable quicker achievement of remission and prevent serious perinatal complications. International Scientific Literature, Inc. 2017-04-18 /pmc/articles/PMC5404478/ /pubmed/28416778 http://dx.doi.org/10.12659/AJCR.902910 Text en © Am J Case Rep, 2017 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Articles Sato, Hiroshi Asami, Yuna Shiro, Reona Aoki, Masato Yasuda, Miki Imai, Saeko Sakai, Rie Oida, Kenji Kawaharamura, Kanako Yano, Hiroko Taguchi, Nao Suzuki, Takako Hirose, Masaya Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy |
title | Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy |
title_full | Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy |
title_fullStr | Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy |
title_full_unstemmed | Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy |
title_short | Steroid Pulse Therapy for De Novo Minimal Change Disease During Pregnancy |
title_sort | steroid pulse therapy for de novo minimal change disease during pregnancy |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404478/ https://www.ncbi.nlm.nih.gov/pubmed/28416778 http://dx.doi.org/10.12659/AJCR.902910 |
work_keys_str_mv | AT satohiroshi steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT asamiyuna steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT shiroreona steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT aokimasato steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT yasudamiki steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT imaisaeko steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT sakairie steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT oidakenji steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT kawaharamurakanako steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT yanohiroko steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT taguchinao steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT suzukitakako steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy AT hirosemasaya steroidpulsetherapyfordenovominimalchangediseaseduringpregnancy |